Anthropic Buys AI Biotech Firm Coefficient Bio

Anthropic has acquired Coefficient Bio, a nascent artificial intelligence startup focused on biotechnology, for approximately $400 million. Coefficient Bio, established recently, was developing an AI-driven platform designed to streamline and optimize the planning stages of drug research and development, including the management of clinical trials. This strategic acquisition by Anthropic signals a significant push into the biotech sector, leveraging AI to accelerate innovation in pharmaceutical discovery and development. The deal underscores the growing trend of AI integration within the life sciences industry, aiming to reduce timelines and enhance the efficiency of bringing new therapies to market.